Company Legal Name
Latest Valuation
Founded Year
Headquarters
Tahoe Therapeutics is a biotechnology company that leverages artificial intelligence models combined with in vivo data to accelerate drug discovery and development. Founded in 2022 and headquartered in South San Francisco, the company differentiates itself by integrating AI-driven computational approaches with real-world biological data to identify therapeutic candidates that can benefit broader patient populations. This hybrid methodology aims to address traditional drug discovery limitations by improving target identification and reducing development timelines. As an early-stage company, Tahoe Therapeutics is focused on building its AI platform capabilities and advancing its pipeline of drug candidates across multiple therapeutic areas.
Availability of information and platform features may vary by region and applicable requirements.
Eligibility and access may depend on user location, verification status, and applicable legal or regulatory requirements.
Additional platform details may be available after account creation, where applicable.
Identity, compliance, and other review steps may be required before access to certain materials or features.
Platform details, if applicable, should be reviewed in account materials before making any decision.
Any economic terms, if applicable, should be reviewed carefully in the relevant materials.
Private market interests may be illiquid, restricted, or difficult to transfer. Users should not assume that any secondary market will be available.
Valuations may reflect past financing rounds or other available information and may not represent a price at which any person can transact.
Company and sector risks may vary by business model, technology development, competition, regulation, and market conditions.
Operational, documentation, custody, or verification processes may involve limitations, delays, or dependencies.
Regulatory, tax, and legal requirements may change and may affect information availability, platform features, or user eligibility.
